Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
This compound is a synthetic small molecule belonging to the class of aminobenzenesulfonamides. Its structure features a pyrimidine ring substituted with an amino and methyl group, linked via a methylene bridge to a benzenesulfonamide core, which is further modified by an (E)-(2‑oxodihydrofuran‑3(2H)‑ylidene)methylamino substituent. It has been cataloged as an experimental molecule in chemical and pharmacological databases but does not have any approved therapeutic indications or known clinical use. The mechanism of action, biological targets, and pharmacological effects are not described in public sources[1][2][7].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on N-[(2-amino-6-methylpyrimidin-4-yl)methyl]-3-{[(E)-(2-oxodihydrofuran-3(2H)-ylidene)methyl]amino}benzenesulfonamide.